Combining artificial intelligence and robotics to develop next-generation medicines
Formulations transform active pharmaceutical ingredients into viable medicines.
Intrepid’s proprietary platform VALIANT harnesses AI and robotics to enable accelerated development of fully optimized formulations of drugs.
VALIANT — Accelerating drug product development
VALIANT is a modular, autonomous laboratory that leverages data-driven experiment planning to optimize formulation compositions and uses robotic laboratory equipment to prepare and characterize formulation candidates in parallel.
Smarter experimentation lets us do more, with less
By harnessing active learning, VALIANT supersedes inefficient design of experiment processes. Every formulation prepared and measured by VALIANT is maximally informed, ensuring every drug we touch is set up for success.
Accurate predictive ML models with less training data
Optimized formulations using fewer experiments and less material per sample
Experimentation enriched by downstream drug development measurements
Broad spectrum modularity
VALIANT’s preparation and characterization equipment is widely reconfigurable, enabling customized workflows that are compatible with all pharmaceutical formulation types.
Flexibility to accommodate any formulation type
VALIANT’s formulation workflows can be configured to support development of any formulation type, from injectable depots to solid dosage forms to nanoparticles for parenteral administration of drugs. Our closed-loop experimentation approach requires minimal drug sample to converge on lead formulation candidates, with throughput ranging from tens to hundreds of unique formulations per day.